Reviewing methods of deep learning for diagnosing COVID-19, its variants and synergistic medicine combinations

Q Rafique, A Rehman, MS Afghan, HM Ahmad… - Computers in Biology …, 2023 - Elsevier
The COVID-19 pandemic has necessitated the development of reliable diagnostic methods
for accurately detecting the novel coronavirus and its variants. Deep learning (DL) …

Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients

BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian… - Jama, 2021 - jamanetwork.com
Methods| Transplant recipients across the US were recruited though social media to
participate in this prospective cohort, and those who underwent SARS-CoV-2 vaccination …

Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications

EC Abebe, TA Dejenie - Frontiers in Immunology, 2023 - frontiersin.org
Neutralizing antibodies (NAbs) are central players in the humoral immunity that defends the
body from SARS-CoV-2 infection by blocking viral entry into host cells and neutralizing their …

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

C Bergamaschi, E Terpos, M Rosati, M Angel, J Bear… - Cell reports, 2021 - cell.com
Early responses to vaccination are important for shaping both humoral and cellular
protective immunity. Dissecting innate vaccine signatures may predict immunogenicity to …

SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

D Mrak, S Tobudic, M Koblischke… - Annals of the …, 2021 - ard.bmj.com
Objectives Evidence suggests that B cell-depleting therapy with rituximab (RTX) affects
humoral immune response after vaccination. It remains unclear whether RTX-treated …

Anti-spike protein assays to determine SARS-CoV-2 antibody levels: a head-to-head comparison of five quantitative assays

T Perkmann, N Perkmann-Nagele, T Koller… - Microbiology …, 2021 - Am Soc Microbiol
Reliable quantification of the antibody response to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is highly relevant, eg, for identifying possible vaccine failure …

Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases

PJ Thuluvath, P Robarts, M Chauhan - Journal of hepatology, 2021 - Elsevier
Background & Aims Liver transplant (LT) recipients or other immunocompromised patients
were not included in the registration trials studying the efficacy of vaccines against SARS …

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

BJ Boyarsky, JA Ruddy, CM Connolly, MT Ou… - Annals of the …, 2021 - ard.bmj.com
The immune response to SARS-CoV-2 messenger RNA (mRNA) vaccines in patients with
rheumatic and musculoskeletal diseases (RMD) is undefined because these individuals …

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy

B Dhakal, S Abedin, T Fenske… - Blood, The Journal …, 2021 - ashpublications.org
COI notes: Dr. Dhakal has served on the advisory board of Takeda, Amgen, and Jansen. He
has received honorarium from Celgene. Mehdi Hamadani reports Research …

High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases

JA Ruddy, CM Connolly, BJ Boyarsky… - Annals of the …, 2021 - ard.bmj.com
SARS-CoV-2 mRNA vaccination elicited high immunogenicity in immunocompetent people
in the original vaccine trials, 1 2 though recent studies have shown blunted immunogenicity …